Not a good buy right now: price is in a strong downtrend and just broke below the S1 support (2.256) with a -10.71% regular-session drop.
No Intellectia buy signals today (AI Stock Picker: no signal; SwingMax: no recent signal), so there’s no high-conviction timing edge to justify buying the dip.
RSI is extremely oversold (RSI_6 9), so a short-term bounce is possible, but with bearish MACD expansion and bearish moving averages, the higher-probability path is continued weakness toward S2 (1.97).
For an impatient investor unwilling to wait for confirmation, the risk/reward is unfavorable; avoid new entries and exit/trim if already holding.
Momentum: MACD histogram is negative (-0.0867) and negatively expanding, signaling accelerating downside pressure.
Mean-reversion setup: RSI_6 at ~9.18 indicates extreme oversold; bounces can occur, but they are lower-quality when trend and MACD remain bearish.
Levels: Pivot 2.72 is far overhead; resistance at 3.185/3.471. Support: S1 2.256 already broken (price ~2.13); next support S2 ~1.97.
Pattern-based short-term odds: Similar-pattern stats imply only modest upside expectations (about +0.65% next day / +1.59% next week), not enough to offset the broader bearish structure.
Wall Street-style cons view: downtrend is dominant, fundamentals show no revenue and worsening losses, and there are no new catalysts or supportive institutional/insider trend data.
Influential/political trading check: No recent congress trading data available in the last 90 days; no signal of political accumulation/distribution.
Wall Street analysts forecast NCNA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NCNA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast NCNA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NCNA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
